Nick Toms
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nick Toms has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Peter J. Roberts
5 shared publicationsEve E. Kelland
School of Biomedical and Molecular Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK
3 shared publicationsGeorge E.N. Kass
3 shared publicationsJohn E. Eriksson
3 shared publicationsLucy M. Elphick
Division of Biochemical Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK
3 shared publicationsAndrey Mikhailov
2 shared publications
Latest Publications
- Open Access
- 7 November 2019
- Published by Springer Nature in BMC Medical Education
- Vol. 19 (1) , 1-11
OncoSim and OncoWiki: an authentic learning approach to teaching cancer genomics
Background: Personalised medicine is rapidly changing the clinical environment, especially in regard to the management of cancer. However, for the large part, methods used to educate undergraduate students as future biomedical scientists and medical doctors have not reflected these changes. In order to make effective use of advances in cancer genomic knowledge, there is a need to expose students to the challenges of genomic medicine and to do so in a manner that makes this complex information accessible. Methods: The teaching method developed, OncoSim, is a scaffolded ‘Personal Research’ module option for final year biomedical undergraduate students. It uses an authentic learning approach to teach cancer genomics via simulated cancer patient case studies that have identifiable potential therapeutic targets with associated drug therapies (so-called targeted therapy/precision oncology). In addition, these simulated case studies can be uploaded to a dedicated learning website (OncoWiki) where they can be freely downloaded and used to teach medical students the principles of targeted therapy. A preliminary evaluation of OncoSim was carried out using 3 research tools: (1) online questionnaires; (2) semi-structured interviews; and (3) analysis of whole cohort mark ranges. Thematic analysis was used to code and categorise interview data. Results: The teaching materials for OncoSim and the OncoWiki site are freely accessible at https://www.oncowiki.co.uk. Questionnaire data and comparison of whole cohort marks showed OncoSim was at least as effective as alternative choices, and suggested OncoSim provided a valued alternative to traditional laboratory-based projects. No barriers to receptiveness were found. Interview analysis provided 5 broad themes (authentic learning experience; individual challenges; interest in cancer; positive learning experience; supportive structure) supporting the authentic learning aspect of the project, the strong scaffolding provided and the overall effectiveness of the approach. Conclusions: Our preliminary, proof-of-concept, evaluation suggests that OncoSim will be effective in supporting the teaching of genomic medicine to undergraduate students. We plan and hope our study will encourage further formal evaluation in a larger cohort of students, including a control group. The OncoWiki site has the capacity to grow independently as future students create and upload simulated case studies for other students to then download and analyse.
- 7 November 2019
- Published by Springer Nature in BMC Medical Education
- Vol. 19 (1) , 1-11
Open AccessOncoSim and OncoWiki: an authentic learning approach to teaching cancer genomics
Background: Personalised medicine is rapidly changing the clinical environment, especially in regard to the management of cancer. However, for the large part, methods used to educate undergraduate students as future biomedical scientists and medical doctors have not reflected these changes. In order to make effective use of advances in cancer genomic knowledge, there is a need to expose students to the challenges of genomic medicine and to do so in a manner that makes this complex information accessible. Methods: The teaching method developed, OncoSim, is a scaffolded ‘Personal Research’ module option for final year biomedical undergraduate students. It uses an authentic learning approach to teach cancer genomics via simulated cancer patient case studies that have identifiable potential therapeutic targets with associated drug therapies (so-called targeted therapy/precision oncology). In addition, these simulated case studies can be uploaded to a dedicated learning website (OncoWiki) where they can be freely downloaded and used to teach medical students the principles of targeted therapy. A preliminary evaluation of OncoSim was carried out using 3 research tools: (1) online questionnaires; (2) semi-structured interviews; and (3) analysis of whole cohort mark ranges. Thematic analysis was used to code and categorise interview data. Results: The teaching materials for OncoSim and the OncoWiki site are freely accessible at https://www.oncowiki.co.uk. Questionnaire data and comparison of whole cohort marks showed OncoSim was at least as effective as alternative choices, and suggested OncoSim provided a valued alternative to traditional laboratory-based projects. No barriers to receptiveness were found. Interview analysis provided 5 broad themes (authentic learning experience; individual challenges; interest in cancer; positive learning experience; supportive structure) supporting the authentic learning aspect of the project, the strong scaffolding provided and the overall effectiveness of the approach. Conclusions: Our preliminary, proof-of-concept, evaluation suggests that OncoSim will be effective in supporting the teaching of genomic medicine to undergraduate students. We plan and hope our study will encourage further formal evaluation in a larger cohort of students, including a control group. The OncoWiki site has the capacity to grow independently as future students create and upload simulated case studies for other students to then download and analyse.
- Open Access
- 1 January 2018
- Published by F1000 Research Ltd in MedEdPublish
- Vol. 7 (3)
A holistic remediation intervention for struggling undergraduate medical students affords sustained Progress Test performance recovery
Introduction: Despite meeting the high standards required to study medicine, a proportion of students struggle to perform consistently to a satisfactory standard. Available literature promotes using more holistic remediation approaches to address any underpinning, often complex multiple interlinked factors associated with chronic student underperformance. Our holistic Level Two remediation intervention draws on principles from Self-Regulated Learner theory, Spaced-Retrieval Practice theory and Motivational Interviewing, and also explores health and wellbeing factors. In this study, we explored the effectiveness of our holistic “Level Two" remediation intervention, offered to chronically struggling Yr1-5 undergraduate medical students, by analysing Progress Test performances. Methods: For Year 1-5 students that were offered Level Two remediation, Progress Test performances pre- and post a Level Two remediation intervention were analysed between 2008-2017. Results: Over this period, 5.9% Year 1-5 students were offered Level Two remediation, with an associated 93% offer acceptance rate. Highest incidence of Level Two remediation occurred in Year 2, then declined significantly over Years 3-5. For all years of study, a significant and sustained enhancement of medical knowledge test performance occurred following remediation. This enhancement did not display any significant gender or ethinicity bias. Conclusions: We conclude that our holistic Level Two remediation pathway correlates with a significant and sustained enhancement of struggling medical students' academic performance. Keywords: Remediation; holistic; medical student; self-regulated learner; Progress Test; undergraduate; medical knowledge Keywords: Remediation; holistic; medical student; self-regulated learner; Progress Test; undergraduate; medical knowledge
- 1 January 2018
- Published by F1000 Research Ltd in MedEdPublish
- Vol. 7 (3)
Open AccessA holistic remediation intervention for struggling undergraduate medical students affords sustained Progress Test performance recovery
Introduction: Despite meeting the high standards required to study medicine, a proportion of students struggle to perform consistently to a satisfactory standard. Available literature promotes using more holistic remediation approaches to address any underpinning, often complex multiple interlinked factors associated with chronic student underperformance. Our holistic Level Two remediation intervention draws on principles from Self-Regulated Learner theory, Spaced-Retrieval Practice theory and Motivational Interviewing, and also explores health and wellbeing factors. In this study, we explored the effectiveness of our holistic “Level Two" remediation intervention, offered to chronically struggling Yr1-5 undergraduate medical students, by analysing Progress Test performances. Methods: For Year 1-5 students that were offered Level Two remediation, Progress Test performances pre- and post a Level Two remediation intervention were analysed between 2008-2017. Results: Over this period, 5.9% Year 1-5 students were offered Level Two remediation, with an associated 93% offer acceptance rate. Highest incidence of Level Two remediation occurred in Year 2, then declined significantly over Years 3-5. For all years of study, a significant and sustained enhancement of medical knowledge test performance occurred following remediation. This enhancement did not display any significant gender or ethinicity bias. Conclusions: We conclude that our holistic Level Two remediation pathway correlates with a significant and sustained enhancement of struggling medical students' academic performance. Keywords: Remediation; holistic; medical student; self-regulated learner; Progress Test; undergraduate; medical knowledge Keywords: Remediation; holistic; medical student; self-regulated learner; Progress Test; undergraduate; medical knowledge
- 1 February 2009
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 235 (1) , 124-134
The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1
- 1 February 2009
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 235 (1) , 124-134
The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1
- 1 October 2008
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 232 (2) , 258-267
Opposing roles for caspase and calpain death proteases in l-glutamate-induced oxidative neurotoxicity
- 1 October 2008
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 232 (2) , 258-267
Opposing roles for caspase and calpain death proteases in l-glutamate-induced oxidative neurotoxicity
- 1 November 2007
- Published by Elsevier in Toxicology
- Vol. 240 (3) , 182-183
Opposing roles for caspase and calpain death proteases in l-glutamate-induced oxidative neurotoxicity
- 1 November 2007
- Published by Elsevier in Toxicology
- Vol. 240 (3) , 182-183
Opposing roles for caspase and calpain death proteases in l-glutamate-induced oxidative neurotoxicity
- 1 May 2007
- Published by Elsevier in European Journal of Pharmacology
- Vol. 562 (1-2) , 68-71
Paracetamol inhibits nitric oxide synthesis in murine spinal cord slices
- 1 May 2007
- Published by Elsevier in European Journal of Pharmacology
- Vol. 562 (1-2) , 68-71
Paracetamol inhibits nitric oxide synthesis in murine spinal cord slices
- 31 December 2006
- Published by Elsevier in NeuroToxicology
- Vol. 27 (6) , 1043-1051
Pyruvate and oxaloacetate limit zinc-induced oxidative HT-22 neuronal cell injury
- 31 December 2006
- Published by Elsevier in NeuroToxicology
- Vol. 27 (6) , 1043-1051
Pyruvate and oxaloacetate limit zinc-induced oxidative HT-22 neuronal cell injury
- 1 September 2006
- Published by Elsevier in Toxicology
- Vol. 226 (1) , 68-69
Modulation of Six1 expression by the anti-mania agents lithium chloride and sodium valproate
- 1 September 2006
- Published by Elsevier in Toxicology
- Vol. 226 (1) , 68-69
Modulation of Six1 expression by the anti-mania agents lithium chloride and sodium valproate
- 1 February 2006
- Published by Elsevier in Analytical Biochemistry
- Vol. 349 (1) , 148-155
Live cell detection of caspase-3 activation by a Discosoma-red-fluorescent-protein-based fluorescence resonance energy transfer construct
- 1 February 2006
- Published by Elsevier in Analytical Biochemistry
- Vol. 349 (1) , 148-155
Live cell detection of caspase-3 activation by a Discosoma-red-fluorescent-protein-based fluorescence resonance energy transfer construct
- 16 January 2004
- Published by Wiley in European Journal of Neuroscience
- Vol. 19 (2) , 287-294
Pyruvate limits zinc‐induced rat oligodendrocyte progenitor cell death
A growing body of evidence suggests that excessive Zn2+ release plays a key role in inducing neuronal death during central nervous system injury. However, the possible cytotoxicity of extracellular Zn2+ to oligodendrocyte lineage cells remains unknown. Employing cultures of rat oligodendrocyte progenitor cells (OPC), we report here that OPC are vulnerable to increased extracellular Zn2+ levels and that pyruvate limits Zn2+‐induced OPC death. Zn2+‐induced concentration‐dependent (pEC50 = −4.1 ± 0.1) OPC death, which was insensitive to both α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor (Evans Blue) and l‐type Ca2+ channel (nicardipine) inhibition. Neither kainate nor nicardipine influenced OPC 65Zn2+ accumulation, in contrast with the Zn2+ ionophore, pyrithione. Cytotoxic extracellular Zn2+ concentrations failed to increase OPC reactive oxygen species production and the antioxidant reagents, trolox, N,N′‐diphenyl‐1,4‐phenylenediamine and N‐tert‐butyl‐α‐phenylnitrone did not afford significant protection from Zn2+ insults. The apoptotic inducer staurosporine induced the appearance of known apoptotic markers [pyknotic nuclei and caspase‐3 specific (120 kDa) α‐fodrin cleavage fragment], events not reproduced with Zn2+ insults. Zn2+ insults were also insensitive to the pan‐caspase inhibitor Z‐VAD‐fmk. However, pyruvate afforded significant OPC protection from lethal Zn2+ insults. We conclude that cultured OPC are vulnerable to Zn2+ insults, via a nonoxidative stress and noncaspase‐3‐based mechanism, involving Zn2+ inhibition of OPC glycolysis.
- 16 January 2004
- Published by Wiley in European Journal of Neuroscience
- Vol. 19 (2) , 287-294
Pyruvate limits zinc‐induced rat oligodendrocyte progenitor cell death
A growing body of evidence suggests that excessive Zn2+ release plays a key role in inducing neuronal death during central nervous system injury. However, the possible cytotoxicity of extracellular Zn2+ to oligodendrocyte lineage cells remains unknown. Employing cultures of rat oligodendrocyte progenitor cells (OPC), we report here that OPC are vulnerable to increased extracellular Zn2+ levels and that pyruvate limits Zn2+‐induced OPC death. Zn2+‐induced concentration‐dependent (pEC50 = −4.1 ± 0.1) OPC death, which was insensitive to both α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor (Evans Blue) and l‐type Ca2+ channel (nicardipine) inhibition. Neither kainate nor nicardipine influenced OPC 65Zn2+ accumulation, in contrast with the Zn2+ ionophore, pyrithione. Cytotoxic extracellular Zn2+ concentrations failed to increase OPC reactive oxygen species production and the antioxidant reagents, trolox, N,N′‐diphenyl‐1,4‐phenylenediamine and N‐tert‐butyl‐α‐phenylnitrone did not afford significant protection from Zn2+ insults. The apoptotic inducer staurosporine induced the appearance of known apoptotic markers [pyknotic nuclei and caspase‐3 specific (120 kDa) α‐fodrin cleavage fragment], events not reproduced with Zn2+ insults. Zn2+ insults were also insensitive to the pan‐caspase inhibitor Z‐VAD‐fmk. However, pyruvate afforded significant OPC protection from lethal Zn2+ insults. We conclude that cultured OPC are vulnerable to Zn2+ insults, via a nonoxidative stress and noncaspase‐3‐based mechanism, involving Zn2+ inhibition of OPC glycolysis.